The results showed that GluOC inhibited the apoptosis of cancer cells via the ROCK1/JAK2/PIK3CA/AKT signalling pathway, promoted cell cycle progression, reduced ROS levels during cancer cell death, and promoted an increase in stem cell properties. This evidence concerns the gene JAK2 and cancer.